Study on SONDA Visual Field Test for Patients with Supra Sellar Tumors
A clinical trial is underway to evaluate the SONDA visual field test's suitability for patients with supra sellar tumors.
Phase III
Oncology / Brain Tumors
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing clinical trial evaluating the SONDA visual field test for supra sellar tumors could significantly influence diagnostic practices in oncology. A successful outcome may lead to its adoption as a standard tool, impacting treatment protocols and patient management strategies.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and any subsequent adoption of the SONDA test in clinical settings.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.